Moderna, Inc. — Director's Dealing 2020

Oct 6, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Moderna, Inc. (MRNA)
CIK: 0001682852
Period of Report: 2020-10-02

Reporting Person: Hoge Stephen (President)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-10-02	Common Stock	M	10000	$.99	Acquired	1936530	Direct
2020-10-02	Common Stock	S	10000	$67.86	Disposed	1926530	Direct
2020-10-05	Common Stock	M	10000	$.99	Acquired	1936530	Direct
2020-10-05	Common Stock	S	10000	$69.50	Disposed	1926530	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-10-02	Stock Option (Right to Buy)	$.99	M	10000	Disposed	2023-08-19	Common Stock (10000)	Direct
2020-10-05	Stock Option (Right to Buy)	$.99	M	10000	Disposed	2023-08-19	Common Stock (10000)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	4116	Indirect

Footnotes

F1: The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on December 27, 2018, as amended on June 1, 2020.

F2: This option is fully vested and exercisable.